TIMELINES

  • TIMELINES

    New activities in Prague

    - by pulse

    Ferring BV entered into a joint-venture with Léciva a.s., the largest pharmaceutical company in the Czech Republic at that time.

  • TIMELINES

    New worldwide subsidiaries

    - by pulse

    During the 1990s, Ferring accelerated the opening of new subsidiaries in Eastern and Western Europe, South America, Asia, South Africa…

  • TIMELINES

    Frederik Paulsen Junior becomes Chairman

    - by pulse

    The founder’s youngest son, Frederik Paulsen, became Chairman of the Ferring Group. At the same time Ferring established Ferring B.V.…

  • TIMELINES

    Launch of PENTASA

    - by pulse

    Ferring launched PENTASA® (mesalazine) for the treatment of inflammatory bowel diseases. This product enabled the company to strengthen its position…

  • TIMELINES

    Launch of MINIRIN tablet

    - by pulse

    The MINIRIN® tablet was the first peptide-based pharmaceutical to be successfully formulated for administration in tablet form.

  • TIMELINES

    Kiel Ferring Foundation

    - by pulse

    Dr. Frederik Paulsen was one of the initiators of the Kiel Ferring Foundation, which, since its formation has awarded 20,000…

  • TIMELINES

    Continuous Expansion

    - by pulse

    Ferring began forming global subsidiaries in Europe, North America and Southeast Asia.

  • TIMELINES

    Launch of GLYPRESSIN

    - by pulse

    First registration and launch of GLYPRESSIN® (terlipressin), an analogue of vasopressin, which is used for the treatment of bleeding oesophageal…

  • TIMELINES

    New production site

    - by pulse

    Ferring established its first production site outside Scandinavia in Kiel, Germany.

  • TIMELINES

    Launch of MINIRIN

    - by pulse

    Ferring launched MINIRIN®, an anti-diuretic hormone used initially to treat diabetes insipidus and later primary nocturnal enuresis, or bedwetting. MINIRIN…

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK